nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.328	1	CbGbCtD
Dopamine—DBH—cranial nerve—amyotrophic lateral sclerosis	0.0286	0.079	CbGeAlD
Dopamine—DBH—peripheral nervous system—amyotrophic lateral sclerosis	0.0188	0.0519	CbGeAlD
Dopamine—POU5F1—cerebellum—amyotrophic lateral sclerosis	0.0164	0.0452	CbGeAlD
Dopamine—DBH—nerve—amyotrophic lateral sclerosis	0.0147	0.0405	CbGeAlD
Dopamine—DBH—hindbrain—amyotrophic lateral sclerosis	0.011	0.0303	CbGeAlD
Dopamine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0105	0.029	CbGeAlD
Dopamine—HTR7—pons—amyotrophic lateral sclerosis	0.0104	0.0286	CbGeAlD
Dopamine—DRD1—nerve—amyotrophic lateral sclerosis	0.00862	0.0238	CbGeAlD
Dopamine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00693	0.0191	CbGeAlD
Dopamine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00691	0.0191	CbGeAlD
Dopamine—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00637	0.0176	CbGeAlD
Dopamine—DBH—brainstem—amyotrophic lateral sclerosis	0.0063	0.0174	CbGeAlD
Dopamine—MAOB—nerve—amyotrophic lateral sclerosis	0.00603	0.0166	CbGeAlD
Dopamine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00559	0.0154	CbGeAlD
Dopamine—HTR7—nerve—amyotrophic lateral sclerosis	0.00539	0.0149	CbGeAlD
Dopamine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00519	0.0143	CbGeAlD
Dopamine—MAOA—nerve—amyotrophic lateral sclerosis	0.00515	0.0142	CbGeAlD
Dopamine—DRD2—nerve—amyotrophic lateral sclerosis	0.00509	0.014	CbGeAlD
Dopamine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00475	0.0131	CbGeAlD
Dopamine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00452	0.0125	CbGeAlD
Dopamine—DBH—medulla oblongata—amyotrophic lateral sclerosis	0.00439	0.0121	CbGeAlD
Dopamine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00422	0.0116	CbGeAlD
Dopamine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00403	0.0111	CbGeAlD
Dopamine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00386	0.0106	CbGeAlD
Dopamine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00381	0.0105	CbGeAlD
Dopamine—DRD1—brainstem—amyotrophic lateral sclerosis	0.0037	0.0102	CbGeAlD
Dopamine—COMT—brainstem—amyotrophic lateral sclerosis	0.00333	0.00918	CbGeAlD
Dopamine—DBH—nervous system—amyotrophic lateral sclerosis	0.0033	0.0091	CbGeAlD
Dopamine—DBH—central nervous system—amyotrophic lateral sclerosis	0.00318	0.00876	CbGeAlD
Dopamine—DBH—cerebellum—amyotrophic lateral sclerosis	0.00311	0.00856	CbGeAlD
Dopamine—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00305	0.00842	CbGeAlD
Dopamine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00297	0.0082	CbGeAlD
Dopamine—DRD4—brain—amyotrophic lateral sclerosis	0.00294	0.00812	CbGeAlD
Dopamine—MAOB—embryo—amyotrophic lateral sclerosis	0.00283	0.0078	CbGeAlD
Dopamine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00272	0.00751	CbGeAlD
Dopamine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00271	0.00747	CbGeAlD
Dopamine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00261	0.00719	CbGeAlD
Dopamine—MAOB—brainstem—amyotrophic lateral sclerosis	0.00259	0.00714	CbGeAlD
Dopamine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00254	0.007	CbGeAlD
Dopamine—DBH—brain—amyotrophic lateral sclerosis	0.00252	0.00696	CbGeAlD
Dopamine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00244	0.00674	CbGeAlD
Dopamine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00242	0.00667	CbGeAlD
Dopamine—MAOA—embryo—amyotrophic lateral sclerosis	0.00241	0.00665	CbGeAlD
Dopamine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.0024	0.00662	CbGeAlD
Dopamine—COMT—medulla oblongata—amyotrophic lateral sclerosis	0.00232	0.0064	CbGeAlD
Dopamine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00231	0.00638	CbGeAlD
Dopamine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00229	0.00632	CbGeAlD
Dopamine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00221	0.0061	CbGeAlD
Dopamine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00219	0.00603	CbGeAlD
Dopamine—COMT—spinal cord—amyotrophic lateral sclerosis	0.00207	0.00571	CbGeAlD
Dopamine—DRD3—brain—amyotrophic lateral sclerosis	0.00207	0.00571	CbGeAlD
Dopamine—DRD5—brain—amyotrophic lateral sclerosis	0.00194	0.00535	CbGeAlD
Dopamine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00194	0.00535	CbGeAlD
Dopamine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00187	0.00515	CbGeAlD
Dopamine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00185	0.0051	CbGeAlD
Dopamine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.00181	0.00498	CbGeAlD
Dopamine—COMT—nervous system—amyotrophic lateral sclerosis	0.00174	0.00481	CbGeAlD
Dopamine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00169	0.00467	CbGeAlD
Dopamine—COMT—central nervous system—amyotrophic lateral sclerosis	0.00168	0.00463	CbGeAlD
Dopamine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00167	0.00461	CbGeAlD
Dopamine—COMT—cerebellum—amyotrophic lateral sclerosis	0.00164	0.00453	CbGeAlD
Dopamine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00161	0.00445	CbGeAlD
Dopamine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.00161	0.00444	CbGeAlD
Dopamine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00156	0.0043	CbGeAlD
Dopamine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00154	0.00425	CbGeAlD
Dopamine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00153	0.00423	CbGeAlD
Dopamine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.0015	0.00415	CbGeAlD
Dopamine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.0015	0.00414	CbGeAlD
Dopamine—DRD1—brain—amyotrophic lateral sclerosis	0.00148	0.00409	CbGeAlD
Dopamine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00148	0.00408	CbGeAlD
Dopamine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00148	0.00407	CbGeAlD
Dopamine—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.00147	0.00404	CbGeAlD
Dopamine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00147	0.00404	CbGeAlD
Dopamine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00144	0.00396	CbGeAlD
Dopamine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00143	0.00394	CbGeAlD
Dopamine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00392	CbGeAlD
Dopamine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00142	0.00391	CbGeAlD
Dopamine—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00389	CbGeAlD
Dopamine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00137	0.00379	CbGeAlD
Dopamine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00137	0.00379	CbGeAlD
Dopamine—MAOB—nervous system—amyotrophic lateral sclerosis	0.00136	0.00374	CbGeAlD
Dopamine—COMT—brain—amyotrophic lateral sclerosis	0.00133	0.00368	CbGeAlD
Dopamine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00131	0.00362	CbGeAlD
Dopamine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.00131	0.0036	CbGeAlD
Dopamine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.00128	0.00352	CbGeAlD
Dopamine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00127	0.0035	CbGeAlD
Dopamine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00127	0.00349	CbGeAlD
Dopamine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00126	0.00347	CbGeAlD
Dopamine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00122	0.00337	CbGeAlD
Dopamine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00121	0.00334	CbGeAlD
Dopamine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00121	0.00334	CbGeAlD
Dopamine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00119	0.00329	CbGeAlD
Dopamine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00119	0.00328	CbGeAlD
Dopamine—SLC22A1—brain—amyotrophic lateral sclerosis	0.00117	0.00323	CbGeAlD
Dopamine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00117	0.00322	CbGeAlD
Dopamine—MAOA—nervous system—amyotrophic lateral sclerosis	0.00116	0.00319	CbGeAlD
Dopamine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00115	0.00316	CbGeAlD
Dopamine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00114	0.00314	CbGeAlD
Dopamine—ADRB1—brain—amyotrophic lateral sclerosis	0.00113	0.00311	CbGeAlD
Dopamine—SLC22A3—brain—amyotrophic lateral sclerosis	0.00112	0.00309	CbGeAlD
Dopamine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00111	0.00307	CbGeAlD
Dopamine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.0011	0.00304	CbGeAlD
Dopamine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00109	0.00301	CbGeAlD
Dopamine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00109	0.00301	CbGeAlD
Dopamine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00108	0.00297	CbGeAlD
Dopamine—MAOB—brain—amyotrophic lateral sclerosis	0.00104	0.00286	CbGeAlD
Dopamine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.001	0.00277	CbGeAlD
Dopamine—HTR1A—brain—amyotrophic lateral sclerosis	0.000969	0.00267	CbGeAlD
Dopamine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000961	0.00265	CbGeAlD
Dopamine—HTR7—brain—amyotrophic lateral sclerosis	0.000926	0.00255	CbGeAlD
Dopamine—MAOA—brain—amyotrophic lateral sclerosis	0.000885	0.00244	CbGeAlD
Dopamine—DRD2—brain—amyotrophic lateral sclerosis	0.000875	0.00241	CbGeAlD
Dopamine—SLC22A5—brain—amyotrophic lateral sclerosis	0.000815	0.00225	CbGeAlD
Dopamine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000688	0.0019	CbGeAlD
Dopamine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000663	0.00183	CbGeAlD
Dopamine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000648	0.00179	CbGeAlD
Dopamine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000526	0.00145	CbGeAlD
Dopamine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000106	0.000342	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000106	0.000341	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.00034	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000105	0.00034	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000105	0.00034	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000105	0.00034	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000104	0.000337	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000104	0.000336	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000104	0.000335	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000103	0.000331	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000103	0.000331	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000101	0.000327	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.95e-05	0.000321	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.94e-05	0.000321	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.86e-05	0.000318	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.84e-05	0.000318	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.83e-05	0.000317	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.83e-05	0.000317	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	9.73e-05	0.000314	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.73e-05	0.000314	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.73e-05	0.000314	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	9.72e-05	0.000314	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.64e-05	0.000311	CbGpPWpGaD
Dopamine—DBH—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.61e-05	0.00031	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.55e-05	0.000308	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.53e-05	0.000308	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.51e-05	0.000307	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.42e-05	0.000304	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.42e-05	0.000304	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.35e-05	0.000302	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.32e-05	0.000301	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.31e-05	0.000301	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	9.24e-05	0.000298	CbGpPWpGaD
Dopamine—COMT—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.16e-05	0.000296	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	9.11e-05	0.000294	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.04e-05	0.000292	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.01e-05	0.000291	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.01e-05	0.000291	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.96e-05	0.000289	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.94e-05	0.000289	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.86e-05	0.000286	CbGpPWpGaD
Dopamine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.68e-05	0.00028	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.67e-05	0.00028	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.58e-05	0.000277	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.58e-05	0.000277	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.57e-05	0.000277	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	8.5e-05	0.000274	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.48e-05	0.000274	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.48e-05	0.000274	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.46e-05	0.000273	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.43e-05	0.000272	CbGpPWpGaD
Dopamine—COMT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.42e-05	0.000272	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.4e-05	0.000271	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.38e-05	0.000271	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.36e-05	0.00027	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	8.36e-05	0.00027	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.35e-05	0.00027	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.27e-05	0.000267	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.24e-05	0.000266	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.21e-05	0.000265	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.13e-05	0.000263	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.13e-05	0.000262	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.99e-05	0.000258	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.98e-05	0.000258	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.91e-05	0.000255	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.85e-05	0.000253	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.78e-05	0.000251	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.74e-05	0.00025	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	7.69e-05	0.000248	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.66e-05	0.000247	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.62e-05	0.000246	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.62e-05	0.000246	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.58e-05	0.000245	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.53e-05	0.000243	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.44e-05	0.00024	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.35e-05	0.000237	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.29e-05	0.000235	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.21e-05	0.000233	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.21e-05	0.000233	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.2e-05	0.000232	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.19e-05	0.000232	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.01e-05	0.000226	CbGpPWpGaD
Dopamine—COMT—Metabolism—APOE—amyotrophic lateral sclerosis	6.93e-05	0.000224	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.91e-05	0.000223	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.88e-05	0.000222	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.82e-05	0.00022	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.75e-05	0.000218	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.73e-05	0.000217	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.68e-05	0.000216	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.63e-05	0.000214	CbGpPWpGaD
Dopamine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	6.57e-05	0.000212	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.51e-05	0.00021	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6.47e-05	0.000209	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.4e-05	0.000207	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.4e-05	0.000207	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	6.33e-05	0.000204	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.33e-05	0.000204	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.3e-05	0.000203	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.27e-05	0.000202	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.23e-05	0.000201	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.19e-05	0.0002	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.13e-05	0.000198	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.11e-05	0.000197	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.03e-05	0.000195	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6e-05	0.000194	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.97e-05	0.000193	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.86e-05	0.000189	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	5.84e-05	0.000189	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.82e-05	0.000188	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.77e-05	0.000186	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.76e-05	0.000186	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.71e-05	0.000184	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.68e-05	0.000183	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.57e-05	0.00018	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	5.56e-05	0.000179	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.51e-05	0.000178	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.45e-05	0.000176	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.4e-05	0.000174	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	5.38e-05	0.000174	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.33e-05	0.000172	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.33e-05	0.000172	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.33e-05	0.000172	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.32e-05	0.000172	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.29e-05	0.000171	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.18e-05	0.000167	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.15e-05	0.000166	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.14e-05	0.000166	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.13e-05	0.000165	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.11e-05	0.000165	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.08e-05	0.000164	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.01e-05	0.000162	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.95e-05	0.00016	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.93e-05	0.000159	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.89e-05	0.000158	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.86e-05	0.000157	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.85e-05	0.000157	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.8e-05	0.000155	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	4.8e-05	0.000155	CbGpPWpGaD
Dopamine—COMT—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.75e-05	0.000153	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.68e-05	0.000151	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.64e-05	0.00015	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.62e-05	0.000149	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.61e-05	0.000149	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.6e-05	0.000148	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.55e-05	0.000147	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.5e-05	0.000145	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.42e-05	0.000143	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.41e-05	0.000143	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.4e-05	0.000142	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.38e-05	0.000141	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.38e-05	0.000141	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.35e-05	0.00014	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.34e-05	0.00014	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.3e-05	0.000139	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.25e-05	0.000137	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.24e-05	0.000137	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.24e-05	0.000137	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.15e-05	0.000134	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000134	CbGpPWpGaD
Dopamine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	4.12e-05	0.000133	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.08e-05	0.000132	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.08e-05	0.000132	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.06e-05	0.000131	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.99e-05	0.000129	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.96e-05	0.000128	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.95e-05	0.000128	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.95e-05	0.000127	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.88e-05	0.000125	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.81e-05	0.000123	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.79e-05	0.000122	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.78e-05	0.000122	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.74e-05	0.000121	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.72e-05	0.00012	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.66e-05	0.000118	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.61e-05	0.000117	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.56e-05	0.000115	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.48e-05	0.000112	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.41e-05	0.00011	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.41e-05	0.00011	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.36e-05	0.000108	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.32e-05	0.000107	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.29e-05	0.000106	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.27e-05	0.000105	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.26e-05	0.000105	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.25e-05	0.000105	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.15e-05	0.000102	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.13e-05	0.000101	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.13e-05	0.000101	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.08e-05	9.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.06e-05	9.88e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3e-05	9.69e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.93e-05	9.46e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-05	9.11e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.81e-05	9.09e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.78e-05	8.96e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.77e-05	8.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.76e-05	8.92e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.74e-05	8.83e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.58e-05	8.33e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.57e-05	8.3e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.53e-05	8.17e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.51e-05	8.12e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.42e-05	7.81e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.41e-05	7.77e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.39e-05	7.71e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.38e-05	7.67e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-05	7.66e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.37e-05	7.65e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.35e-05	7.59e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.34e-05	7.55e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.27e-05	7.34e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.23e-05	7.18e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	7.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.17e-05	6.99e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	6.98e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.14e-05	6.9e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.13e-05	6.89e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.12e-05	6.86e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.09e-05	6.75e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.05e-05	6.61e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.04e-05	6.59e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.02e-05	6.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.01e-05	6.49e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-05	6.3e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.95e-05	6.29e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.86e-05	6.01e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.85e-05	5.96e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.84e-05	5.94e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.84e-05	5.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.81e-05	5.86e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	5.79e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.78e-05	5.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.76e-05	5.68e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.65e-05	5.34e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.64e-05	5.28e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.61e-05	5.2e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.58e-05	5.1e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.55e-05	4.99e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.54e-05	4.98e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.52e-05	4.91e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.39e-05	4.48e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.39e-05	4.48e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.37e-05	4.42e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.34e-05	4.31e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.25e-05	4.03e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-05	3.97e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	3.93e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.19e-05	3.86e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.05e-05	3.39e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.04e-05	3.36e-05	CbGpPWpGaD
